Intraneuronal Aβ Causes the Onset of Early Alzheimer’s Disease-Related Cognitive Deficits in Transgenic Mice

Cited by (1,000)

Items 301–400 of 1,000

1. A key role for the microglial NADPH oxidase in APP-dependent killing of neurons
   Bin Qin, Laetitia Cartier, Michel Dubois‐Dauphin, Bin Li, Lena Serrander, Karl‐Heinz Krause · 2005 · Neurobiology of Aging
2. Age-related accumulation of Reelin in amyloid-like deposits
   Knuesel, Irene, Nyffeler, Myriel, Mormède, Cecile, Muhia, Mary, Meyer, Urs, Pietropaolo, Susanna, Yee, Benjamin K., Pryce, Christopher R., LaFerla, Frank M., Marighetto, Aline et al. · 2009 · Neurobiology of Aging
3. Early intervention with a small molecule inhibitor for tumor nefosis factor-α prevents cognitive deficits in a triple transgenic mouse model of Alzheimer’s disease
   S. Prasad Gabbita, Minu K. Srivastava, Pirooz Eslami, Ming F. Johnson, Naomi Kobritz, David Tweedie, Nigel H. Greig, Frank P. Zemlan, Sherven P. Sharma, Marni E. Harris‐White · 2012 · Journal of Neuroinflammation
4. Selecting a Mouse Model of Alzheimer’s Disease
   Jeannie Chin · 2010 · Methods in molecular biology
5. Central insulin resistance and synaptic dysfunction in intracerebroventricular-streptozotocin injected rodents
   Brian C. Shonesy, Thiruchelvam Kariharan, Kodeeswaran Parameshwaran, Engy Abdel Rahman, Senthilkumar S. Karuppagounder, Kevin W. Huggins, Carl A. Pinkert, Rajesh Amin, Muralikrishnan Dhanasekaran, Vishnu D. Suppiramaniam · 2011 · Neurobiology of Aging
6. Prolonged running, not fluoxetine treatment, increases neurogenesis, but does not alter neuropathology, in the 3xTg mouse model of Alzheimer’s disease
   Marlatt, Michael W., Potter, Michelle C., Bayer, Thomas A., van Praag, Henriette, Lucassen, Paul J. · 2013 · Current Topics in Behavioral Neurosciences
7. Reference and working memory deficits in the 3xTg-AD mouse between 2 and 15-months of age: a cross-sectional study
   Stevens, Leanne M., Brown, Richard E. · 2015 · Behavioural Brain Research
8. Mice as models: Transgenic approaches and Alzheimer's disease
   Dora Games, Manuel Buttini, Dione T. Kobayashi, Dale Schenk, Peter A. Seubert · 2006 · Journal of Alzheimer s Disease
9. A novel glycogen synthase kinase‐3 inhibitor 2‐methyl‐5‐(3‐{4‐[(S )‐methylsulfinyl]phenyl}‐1‐benzofuran‐5‐yl)‐1,3,4‐oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer’s disease
   Tomohiro Onishi, Hiroki Iwashita, Yumiko Uno, Jun Kunitomo, Morihisa Saitoh, Eiji Kimura, Hisashi Fujita, Noriko Uchiyama, Masakuni Kori, Masayuki Takizawa · 2011 · Journal of Neurochemistry
10. Amyloid beta and the longest-lived rodent: the naked mole-rat as a model for natural protection from Alzheimer's disease
    Yael H. Edrey, David X. Medina, Maria E. Gaczynska, Paweł A. Osmulski, Salvatore Oddo, Antonella Caccamo, Rochelle Buffenstein · 2013 · Neurobiology of Aging
11. Protective Effects of Positive Lysosomal Modulation in Alzheimer's Disease Transgenic Mouse Models
    David Butler, Jeannie Hwang, Candice Estick, A. Nishiyama, S. Kumar, C. Baveghems, Hollie B. Young-Oxendine, Meagan L. Wisniewski, Ana Charalambides, B. Bahr · 2011 · PLoS ONE
12. Aβ Internalization by Neurons and Glia
    Amany Mohamed, E Chaves · 2011 · International Journal of Alzheimer s Disease
13. Blocking the Interaction between Apolipoprotein E and Aβ Reduces Intraneuronal Accumulation of Aβ and Inhibits Synaptic Degeneration
    Kuszczyk, Magdalena A., Sanchez, Sandrine, Pankiewicz, Joanna, Kim, Jungsu, Duszczyk, Malgorzata, Guridi, Maitea, Asuni, Ayodeji A., Sullivan, Patrick M., Holtzman, David M., Sadowski, Martin J. · 2013 · The American Journal of Pathology
14. Oxidative stress modulating nanomaterials and their biochemical roles in nanomedicine
    Kapil Dev Patel, Zalike Keskin‐Erdogan, Prasad Sawadkar, Nik Syahirah Aliaa Nik Sharifulden, Mark Robert Shannon, Madhumita Patel, Lady V. Barrios Silva, Rajkumar Patel, David Y. S. Chau, Jonathan Campbell Knowles et al. · 2024 · Nanoscale Horizons
15. Endothelin-converting Enzymes Degrade Intracellular β-Amyloid Produced within the Endosomal/Lysosomal Pathway and Autophagosomes*
    Javier Pacheco-Quinto, E. Eckman · 2013 · Journal of Biological Chemistry
16. Autophagy: A cell repair mechanism that retards ageing and age-associated diseases and can be intensified pharmacologically
    Ettore Bergamini · 2006 · Molecular Aspects of Medicine
17. Neuroprotective effects of bee venom phospholipase A2 in the 3xTg AD mouse model of Alzheimer’s disease
    Minsook Ye, Hwan‐Suck Chung, Chanju Lee, Moon Sik Yoon, Abigail Yu, Jin Su Kim, Deok‐Sang Hwang, Insop Shim, Hyunsu Bae · 2016 · Journal of Neuroinflammation
18. Depressive-Like Behavior Is Paired to Monoaminergic Alteration in a Murine Model of Alzheimer's Disease
    Adele Romano, Lorenzo Pace, Bianca Tempesta, Angelo Michele Lavecchia, Teresa Macheda, Gaurav Bedse, Alessandro Petrella, Carlo Cifani, Gaetano Serviddio, Gianluigi Vendemiale et al. · 2014 · The International Journal of Neuropsychopharmacology
19. A novel tricyclic pyrone compound ameliorates cell death associated with intracellular amyloid‐β oligomeric complexes
    Izumi Maezawa, Hyun‐Seok Hong, Hui‐Chuan Wu, Srinivas K. Battina, Sandeep Rana, Takeo Iwamoto, Gary A. Radke, Erik Pettersson, George M. Martin, Duy H. Hua et al. · 2006 · Journal of Neurochemistry
20. APP/PS1KI bigenic mice develop early synaptic deficits and hippocampus atrophy
    Breyhan, Henning, Wirths, Oliver, Duan, Kailai, Marcello, Andrea, Rettig, Jens, Bayer, Thomas A. · 2009 · Acta Neuropathologica
21. Formulation of a Medical Food Cocktail for Alzheimer's Disease: Beneficial Effects on Cognition and Neuropathology in a Mouse Model of the Disease
    Parachikova, Anna, Green, Kim N., Hendrix, Curt, LaFerla, Frank M. · 2010 · PLoS ONE
22. Aβ1-42 monomers or oligomers have different effects on autophagy and apoptosis
    Michela Guglielmotto, Debora Monteleone, Antonio Piras, Valeria Valsecchi, Marta Tropiano, Stefania Ariano, Michele Fornaro, Alessandro Vercelli, Julien Puyal, Ottavio Arancio et al. · 2014 · Autophagy
23. Aβ accumulation causes MVB enlargement and is modelled by dominant negative VPS4A
    Willén, Katarina, Edgar, James R., Hasegawa, Takafumi, Tanaka, Nobuyuki, Futter, Clare E., Gouras, Gunnar K. · 2017 · Molecular Neurodegeneration
24. Neuroprotective Effects of Chronic Resveratrol Treatment and Exercise Training in the 3xTg-AD Mouse Model of Alzheimer’s Disease
    Tom L. Broderick, Suhail Rasool, Rongzi Li, Yuxian Zhang, Miranda Anderson, Layla Al‐Nakkash, Jeffrey H. Plochocki, Thangiah Geetha, Jeganathan Ramesh Babu · 2020 · International Journal of Molecular Sciences
25. The Impact of Surgery and Anesthesia on Post-Operative Cognitive Decline and Alzheimer's Disease Development: Biomarkers and Preventive Strategies
    Ayush K. Kapila, Helena R. Watts, Tianlong Wang, Daqing Ma · 2014 · Journal of Alzheimer s Disease
26. A review of genome mutation and Alzheimer's disease
    P. Thomas, Michael Felix Fenech · 2006 · Mutagenesis
27. The BET-Bromodomain Inhibitor JQ1 Reduces Inflammation and Tau Phosphorylation at Ser396 in the Brain of the 3xTg Model of Alzheimer's Disease
    Marco Magistri, Dmitry Velmeshev, Madina Makhmutova, Prutha Patel, Gregory C. Sartor, Claude‐Henry Volmar, Claes Wahlestedt, Mohammad Ali Faghihi · 2016 · Current Alzheimer Research
28. Beta-amyloid disrupted synaptic vesicle endocytosis in cultured hippocampal neurons
    Kelly, B.L., Ferreira, A. · 2007 · Neuroscience
29. Synaptic dysfunction in early phases of Alzheimer's Disease
    Silvia Pelucchi, Fabrizio Gardoni, Mónica Di Luca, Elena E. Marcello · 2022 · Handbook of clinical neurology
30. Amyloid-β Peptides Stimulate the Expression of the p75NTR Neurotrophin Receptor in SHSY5Y Human Neuroblastoma Cells and AD Transgenic Mice
    Balu Chakravarthy, Chantal Gaudet, Michel Ménard, Trevor G. Atkinson, Leslie Brown, Frank M. LaFerla, Ubaldo Armato, James Whitfield · 2010 · Journal of Alzheimer s Disease
31. Alterations in synaptic plasticity coincide with deficits in spatial working memory in presymptomatic 3xTg-AD mice
    Jason K. Clark, Matthew Furgerson, Jonathon D. Crystal, Marcus Fechheimer, Ruth Furukawa, John J. Wagner · 2015 · Neurobiology of Learning and Memory
32. Human and rodent amyloid-β peptides differentially bind heme: Relevance to the human susceptibility to Alzheimer’s disease
    Hani Atamna, William H. Frey, Novie Ko · 2009 · Archives of Biochemistry and Biophysics
33. Pharmacologic reversal of neurogenic and neuroplastic abnormalities and cognitive impairments without affecting Aβ and tau pathologies in 3xTg-AD mice
    Blanchard, Julie, Wanka, Lukas, Tung, Yunn-Chyn, Cárdenas-Aguayo, María del Carmen, LaFerla, Frank M., Iqbal, Khalid, Grundke-Iqbal, Inge · 2010 · Acta Neuropathologica
34. Dopaminergic neurotransmission dysfunction induced by amyloid-β transforms cortical long-term potentiation into long-term depression and produces memory impairment
    Moreno-Castilla, Perla, Rodriguez-Duran, Luis F., Guzman-Ramos, Kioko, Barcenas-Femat, Alejandro, Escobar, Martha L., Bermudez-Rattoni, Federico · 2016 · Neurobiology of Aging
35. Autoimmune Manifestations in the 3xTg-AD Model of Alzheimer's Disease
    Marchese, Monica, Cowan, David, Head, Elizabeth, Ma, Donglai, Karimi, Khalil, Ashthorpe, Vanessa, Kapadia, Minesh, Zhao, Hui, Davis, Paulina, Sakic, Boris · 2014 · Journal of Alzheimer's Disease
36. Exenatide promotes cognitive enhancement and positive brain metabolic changes in PS1-KI mice but has no effects in 3xTg-AD animals
    Manuela Bomba, Domenico Ciavardelli, Elena Silvestri, Lorella M.T. Canzoniero, Rossano Lattanzio, Paula Blandina Ola Chiappini, Mauro Piantelli, Chiara Di Ilio, Agostino Consoli, Stefano Luca Sensi · 2013 · Cell Death and Disease
37. Cholesterol depletion reduces aggregation of amyloid-beta peptide in hippocampal neurons
    Anja Schneider, Walter Schulz‐Schaeffer, Tobias Hartmann, Jörg Bernhard Schulz, Mikael Simons · 2006 · Neurobiology of Disease
38. Neurovascular uncoupling in the triple transgenic model of Alzheimer's disease: Impaired cerebral blood flow response to neuronal-derived nitric oxide signaling
    Cátia F. Lourenço, Ana Ledo, Rui M. Barbosa, João A.N. Laranjinha · 2017 · Experimental Neurology
39. Differential deregulation of NGF and BDNF neurotrophins in a transgenic rat model of Alzheimer's disease
    M. Florencia Iulita, María Beatriz Bistué Millón, Rowan Pentz, Lisi Flores Aguilar, Sonia Do Carmo, Simon T. M. Allard, Bernadeta Michalski, Edward N. Wilson, Adriana Ducatenzeiler, Martin Alejandro Bruno et al. · 2017 · Neurobiology of Disease
40. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease
    Syed Faraz Kazim, Julie Blanchard, Chun‐Ling Dai, Yunn Chyn Tung, Frank M. LaFerla, Inge-Grundke Iqbal, Khalid Iqbal · 2014 · Neurobiology of Disease
41. Neural stem cell transplantation enhances mitochondrial biogenesis in a transgenic mouse model of Alzheimer's disease–like pathology
    Wei Zhang, Guo-Jun Gu, Xing Shen, Qi Zhang, Gangmin Wang, Peijun Wang · 2014 · Neurobiology of Aging
42. Age-dependent phenotypic characteristics of a triple transgenic mouse model of Alzheimer disease.
    Susanna Pietropaolo, Joram Feldon, Benjamin K. Yee · 2008 · Behavioral Neuroscience
43. Trafficking, a key player in regulated intramembrane proteolysis
    Ragna Sannerud, Wim G. Annaert · 2008 · Seminars in Cell and Developmental Biology
44. Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer’s disease by exerting anti-inflammatory and neuroprotective effects
    Caterina Scuderi, Maria Rosanna Bronzuoli, Roberta Facchinetti, Lorenzo Pace, Luca Ferraro, Kevin D. Broad, Gaetano Serviddio, Francesco Bellanti, Gianmauro Palombelli, Giulia Carpinelli et al. · 2018 · Translational Psychiatry
45. Episodic-Like Memory for What-Where-Which Occasion is Selectively Impaired in the 3xTgAD Mouse Model of Alzheimer's Disease
    Davis, Katherine E., Easton, Alexander, Eacott, Madeline J., Gigg, John · 2013 · Journal of Alzheimer's Disease
46. Imaging of cerebrovascular pathology in animal models of Alzheimer's disease
    Klohs, Jan, Rudin, Markus, Shimshek, Derya R., Beckmann, Nicolau · 2014 · Frontiers in Aging Neuroscience
47. Reelin-immunoreactive neurons in entorhinal cortex layer II selectively express intracellular amyloid in early Alzheimer's disease
    Asgeir Kobro‐Flatmoen, Anne Nagelhus, Menno P. Witter · 2016 · Neurobiology of Disease
48. Cryptotanshinone, a compound from Salvia miltiorrhiza modulates amyloid precursor protein metabolism and attenuates β-amyloid deposition through upregulating α-secretase in vivo and in vitro
    Zhengrong Mei, Fangyan Zhang, Liang Tao, Wenhua Zheng, Yingnan Cao, Zhaohe Wang, Shu Tang, Kang Le, Shaorui Chen, Rongbiao Pi et al. · 2009 · Neuroscience Letters
49. Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids
    A. Currais, O. Quehenberger, Aaron M. Armando, Daniel J. Daugherty, P. Maher, D. Schubert · 2016 · npj Aging and Mechanisms of Disease
50. Gender-Specific Neuroimmunoendocrine Aging in a Triple-Transgenic 3×Tg-AD Mouse Model for Alzheimer’s Disease and Its Relation with Longevity
    Giménez-Llort, Lydia, Arranz, Lorena, Maté, Ianire, De la Fuente, Mónica · 2008 · Neuroimmunomodulation
51. Estrogen and Hippocampal Plasticity in Rodent Models
    Michael R. Foy, Michel Baudry, Roberta Dı́az Brinton, Richard F. Thompson · 2008 · Journal of Alzheimer s Disease
52. Synaptic plasticity disruption by amyloid β protein: modulation by potential Alzheimer's disease modifying therapies
    Michael J. Rowan, Igor V. Klyubin, Qingyong Wang, Roger Anwyl · 2005 · Biochemical Society Transactions
53. Murine models of Alzheimer's disease and their use in developing immunotherapies
    Thomas Wısnıewskı, Einar M. Sigurdsson · 2010 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
54. Drug discovery: selecting the optimal approach
    Frank Sams‐Dodd · 2006 · Drug Discovery Today
55. Evidence of intraneuronal Aβ accumulation preceding tau pathology in the entorhinal cortex
    Lindsay A. Welikovitch, Sonia Do Carmo, Zsófia Maglóczky, Péter Szocsics, János Lőke, Tamás F. Freund, A. Claudio Cuello · 2018 · Acta Neuropathologica
56. Alzheimer's Disease and Amyloid: Culprit or Coincidence?
    Stephen D. Skaper · 2012 · International review of neurobiology
57. Dl-3-n-butylphthalide-induced upregulation of antioxidant defense is involved in the enhancement of cross talk between CREB and Nrf2 in an Alzheimer's disease mouse model
    Chunyan Wang, Zhan‐You Wang, Jingwei Xie, Tao Wang, Xu Wang, Ye Xu, Jianhui Cai · 2015 · Neurobiology of Aging
58. Alzheimer's Aβ fused to green fluorescent protein induces growth stress and a heat shock response
    Jo Caine, Sonia E. Sankovich, Helma Antony, Lynne J. Waddington, Peter Ian Macreadie, J.N. Varghese, Ian George Macreadie · 2007 · FEMS Yeast Research
59. New therapeutic targets in Alzheimer's disease: brain deregulation of calcium and zinc
    Carlo Corona, Anna Pensalfini, Valério Frazzini, Stefano Luca Sensi · 2011 · Cell Death and Disease
60. Olive Oil Phenols as Promising Multi-targeting Agents Against Alzheimer’s Disease
    Stefania Rigacci · 2015 · Advances in experimental medicine and biology
61. APP transgenic mice: their use and limitations
    Balducci, Claudia, Forloni, Gianluigi · 2011 · NeuroMolecular Medicine
62. Neurotoxic β-amyloid oligomers cause mitochondrial dysfunction—the trigger for PANoptosis in neurons
    Xiangyuan Meng, Qi Song, Zinan Liu, Xinpeng Liu, Yujie Wang, Jinyu Liu · 2024 · Frontiers in Aging Neuroscience
63. Hypercholesterolemia accelerates intraneuronal accumulation of Aβ oligomers resulting in memory impairment in Alzheimer's disease model mice
    Tomohiro Umeda, Takami Tomiyama, Erika Kitajima, Toshiki Idomoto, Sachiko Nomura, Mary P. Lambert, William L. Klein, Hiroshi Mori · 2012 · Life Sciences
64. Monoacylglycerol lipase inhibitor JZL184 reduces neuroinflammatory response in APdE9 mice and in adult mouse glial cells
    Rea Pihlaja, Jatta S. Helin, Olli Eskola, Jenni Vasara, Francisco R. Lopez‐Picon, Merja Haaparanta‐Solin, Juha O. Rinne · 2015 · Journal of Neuroinflammation
65. Human mitochondrial transcriptional factor A breaks the mitochondria-mediated vicious cycle in Alzheimer’s disease
    Oka, Sugako, Leon, Julio, Sakumi, Kunihiko, Ide, Tomomi, Kang, Dongchon, LaFerla, Frank M., Nakabeppu, Yusaku · 2016 · Scientific Reports
66. Role of sex and high-fat diet in metabolic and hypothalamic disturbances in the 3xTg-AD mouse model of Alzheimer’s disease
    Lisa S. Robison, Olivia J. Gannon, Melissa A. Thomas, Abigail E. Salinero, Charly Abi‐Ghanem, Yannick Poitelon, Sophie Belin, Kristen L. Zuloaga · 2020 · Journal of Neuroinflammation
67. Retinoic acid receptor‐α signalling antagonizes both intracellular and extracellular amyloid‐β production and prevents neuronal cell death caused by amyloid‐β
    Christopher I Jarvis, Maria Beatriz C.V. Goncalves, Earl E. Clarke, Mehtap Dogruel, S. Barret Kalindjian, Sarah Ann Thomas, Malcolm Maden, Jonathan P. T. Corcoran · 2010 · European Journal of Neuroscience
68. COL25A1 triggers and promotes Alzheimer’s disease-like pathology in vivo
    Ying Tong, Ying Xu, Kimberly A. Scearce-Levie, Louis J. Ptáček, Ying‐Hui Fu · 2009 · Neurogenetics
69. Sex-Dependent Alterations in Social Behaviour and Cortical Synaptic Activity Coincide at Different Ages in a Model of Alzheimer’s Disease
    Cyril Bories, Matthieu J. Guitton, Carl Julien, Cyntia Tremblay, Milène Vandal, Meriem Msaid, Yves De Koninck, Frédéric Calon · 2012 · PLoS ONE
70. Notoginsenoside R1 attenuates amyloid-β-induced damage in neurons by inhibiting reactive oxygen species and modulating MAPK activation
    Bo Ma, Xiangbao Meng, Jing Wang, Jing Sun, Xiaoyu Ren, Meng Qin, Jie Sun, Guibo Sun, Xiaobo Sun · 2014 · International Immunopharmacology
71. Cathepsin B Improves ß-Amyloidosis and Learning and Memory in Models of Alzheimer’s Disease
    Christine M. Embury, Bhagyalaxmi Dyavarshetty, Yaman Lu, Jayme L. Wiederin, Pawel S. Ciborowski, Howard Eliot Gendelman, Tomomi Kiyota · 2016 · Journal of Neuroimmune Pharmacology
72. Islet amyloid polypeptide: Another key molecule in Alzheimer’s pathogenesis?
    Yun Zhang, Weihong Song · 2017 · Progress in Neurobiology
73. The problem of genotype and sex differences in life expectancy in transgenic AD mice
    Eric A. Rae, Richard E. Brown · 2015 · Neuroscience & Biobehavioral Reviews
74. Amyloid β-Protein Assembly: The Effect of Molecular Tweezers CLR01 and CLR03
    Xueyun Zheng, Deyu Liu, Frank‐Gerrit Klärner, Thomas H. Schrader, Gal Bitan, Michael T. Bowers · 2015 · The Journal of Physical Chemistry B
75. GRK5 deficiency leads to early Alzheimer-like pathology and working memory impairment
    Zhiming Suo, April Cox, Nicholas L. Bartelli, Imtiaz Rasul, Barry W. Festoff, Richard T. Premont, Gary W. Arendash · 2006 · Neurobiology of Aging
76. Heme binding to Amyloid-β peptide: Mechanistic role in Alzheimer's disease
    Hani Atamna · 2006 · Journal of Alzheimer s Disease
77. A Humanin Derivative Reduces Amyloid Beta Accumulation and Ameliorates Memory Deficit in Triple Transgenic Mice
    Takako Niikura, Elkhansa Sidahmed, Chiho Hirata‐Fukae, Paul S. S Aisen, Yasuji Matsuoka · 2011 · PLoS ONE
78. Single cell gene expression profiling in Alzheimer’s disease
    Stephen D. Ginsberg, Shaoli Che, Scott Counts, Elliott Jay Mufson · 2006 · NeuroRx
79. Anti-dementia drugs and hippocampal-dependent memory in rodents
    Carla M. Yuede, Hongxin Dong, John G. Csernansky · 2007 · Behavioural Pharmacology
80. Blocking ADAM10 synaptic trafficking generates a model of sporadic Alzheimer’s disease
    Roberta Epis, Elena E. Marcello, Fabrizio Gardoni, Csaba Vastagh, Matteo Malinverno, Claudia Balducci, Alessio Vittorio Colombo, Barbara Borroni, Hugo Vara, Mario Dell’Agli et al. · 2010 · Brain
81. Bioactive Food Abates Metabolic and Synaptic Alterations by Modulation of Gut Microbiota in a Mouse Model of Alzheimer’s Disease
    Tauqeerunnisa Syeda, Mónica Sánchez‐Tapia, Laura Pinedo‐Vargas, Omar Granados, Daniel Cuervo-Zanatta, Eleazar Rojas-Santiago, Sofía Y. Díaz-Cintra, Nimbe Torres, Claudia Perez‐Cruz · 2018 · Journal of Alzheimer s Disease
82. Systemic vaccination with anti‐oligomeric monoclonal antibodies improves cognitive function by reducing Aβ deposition and tau pathology in 3xTg‐AD mice
    Suhail Rasool, Hilda Martínez‐Coria, Jessica Wu, Frank M. LaFerla, Charles G. Glabe · 2013 · Journal of Neurochemistry
83. Neuroprotective Effects of Baicalein, Wogonin, and Oroxylin A on Amyloid Beta-Induced Toxicity via NF-κB/MAPK Pathway Modulation
    Yeongseon Ji, Jin Han, Nayoung Lee, Jeong-Hyun Yoon, Kumju Youn, Hyun Joo Ha, Eunju Yoon, Dong Hyun Kim, Mira Jun · 2020 · Molecules
84. Helicobacter pylori filtrate impairs spatial learning and memory in rats and increases β-amyloid by enhancing expression of presenilin-2
    Xiulian Wang, Ji Zeng, Jin Feng, Yitao Tian, Yujian Liu, Mei Qiu, Yan Xiong, Yang Yang, Yan Xiong, Zhihua Zhang et al. · 2014 · Frontiers in Aging Neuroscience
85. Sulforaphane epigenetically enhances neuronal BDNF expression and TrkB signaling pathways
    Jisung Kim, Siyoung Lee, Bo‐Ryoung Choi, Hee Seok Yang, Youjin Hwang, Jung Han Yoon Park, Frank M. LaFerla, Jung‐Soo Han, Ki Won Lee, Jiyoung Kim · 2016 · Molecular Nutrition & Food Research
86. Therapeutic potential of nuclear receptor agonists in Alzheimer's disease
    Miguel Moutinho, Gary E. Landreth · 2017 · Journal of Lipid Research
87. Rodent Models of Amyloid-Beta Feature of Alzheimer’s Disease: Development and Potential Treatment Implications
    Chi Him Poon, Yingyi Wang, Man‐Lung Fung, Chengfei Zhang, Lee Wei Lim · 2020 · Aging and Disease
88. Mapping cellular transcriptosomes in autopsied Alzheimer's disease subjects and relevant animal models
    P. Hemachandra Reddy, Shannon K. McWeeney · 2005 · Neurobiology of Aging
89. Increased Hippocampal Excitability in the 3xTgAD Mouse Model for Alzheimer's Disease In Vivo
    Katherine E. Davis, Sarah Fox, John Gigg · 2014 · PLoS ONE
90. Overexpression of Neprilysin Reduces Alzheimer Amyloid-β42 (Aβ42)-induced Neuron Loss and Intraneuronal Aβ42 Deposits but Causes a Reduction in cAMP-responsive Element-binding Protein-mediated Transcription, Age-dependent Axon Pathology, and Premature Death in Drosophila
    Kanae Iijima‐Ando, Stephen Hearn, Linda Granger, Christopher Shenton, Anthony Gatt, Hsueh‐Cheng Chiang, Inessa Hakker, Yi Zhong, Koichi Iijima · 2008 · Journal of Biological Chemistry
91. Tyrosine phosphorylation of tau accompanies disease progression in transgenic mouse models of tauopathy
    Kiran Bhaskar, G. Aaron Hobbs, S-H. Yen, Gloria S. Lee · 2010 · Neuropathology and Applied Neurobiology
92. FBL2 Regulates Amyloid Precursor Protein (APP) Metabolism by Promoting Ubiquitination-Dependent APP Degradation and Inhibition of APP Endocytosis
    Tomomichi Watanabe, Yukiko Hikichi, Antje Willuweit, Yasushi Shintani, Takashi Horiguchi · 2012 · Journal of Neuroscience
93. DPP-4 inhibitor improves learning and memory deficits and AD-like neurodegeneration by modulating the GLP-1 signaling
    Shuyi Chen, Mei Ling Zhou, Jie Sun, Ai Wei Guo, Roger Lakmal Fernando, Yanlin Chen, Peng Peng, Gang Zhao, Yanqiu Deng · 2019 · Neuropharmacology
94. A New Paradigm for the Treatment of Alzheimer's Disease: Targeting Vascular Activation
    Paula Grammas, Joseph M. Martinez, Alma C. Sanchez, Xiangling Yin, Jarred Riley, Dylan Gay, Katherine Desobry, Debjani Tripathy, Jinhua Luo, Marianne Evola et al. · 2014 · Journal of Alzheimer s Disease
95. Prion-like seeding and nucleation of intracellular amyloid-β
    Tomas T. Olsson, Oxana l. Klementieva, Gunnar K. Gouras · 2018 · Neurobiology of Disease
96. Neuronal Autophagy: Self-eating or Self-cannibalism in Alzheimer’s Disease
    Marzena Ułamek-Kozioł, Wanda Furmaga-Jabłońska, Sławomir Januszewski, Judyta Brzozowska, Małgorzata Ściślewska, Mirosław Jabłoński, Ryszard M. Pluta · 2013 · Neurochemical Research
97. Aβ-directed Single-chain Antibody Delivery Via a Serotype-1 AAV Vector Improves Learning Behavior and Pathology in Alzheimer's Disease Mice
    Deborah A. Ryan, Michael A. Mastrangelo, Wade C. Narrow, Mark A. Sullivan, Howard J. Federoff, William J. Bowers · 2010 · Molecular Therapy
98. Cognitive and emotional profiles of aged Alzheimer's disease (3×TgAD) mice: effects of environmental enrichment and sexual dimorphism.
    G. Blázquez, T. Cañete, A. Tobeña, L. Giménez-Llort, A. Fernández-Teruel · 2014 · Behavioural Brain Research
99. Isoprenoids and Alzheimer's disease: A complex relationship
    Sarah L. Cole, Robert J. Vassar · 2006 · Neurobiology of Disease
100. Modulation of 5-Lipoxygenase in Proteotoxicity and Alzheimer's Disease
     Elvira Valera, Richard Dargusch, Pamela A Maher, David Schubert · 2013 · Journal of Neuroscience